1. Home
  2. SRPT vs LIDRW Comparison

SRPT vs LIDRW Comparison

Compare SRPT & LIDRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • LIDRW
  • Stock Information
  • Founded
  • SRPT 1980
  • LIDRW N/A
  • Country
  • SRPT United States
  • LIDRW United States
  • Employees
  • SRPT N/A
  • LIDRW 45
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • LIDRW Auto Parts:O.E.M.
  • Sector
  • SRPT Health Care
  • LIDRW Consumer Discretionary
  • Exchange
  • SRPT Nasdaq
  • LIDRW Nasdaq
  • Market Cap
  • SRPT N/A
  • LIDRW N/A
  • IPO Year
  • SRPT 1997
  • LIDRW 2021
  • Fundamental
  • Price
  • SRPT $36.27
  • LIDRW $0.06
  • Analyst Decision
  • SRPT Buy
  • LIDRW
  • Analyst Count
  • SRPT 23
  • LIDRW 0
  • Target Price
  • SRPT $131.09
  • LIDRW N/A
  • AVG Volume (30 Days)
  • SRPT 4.0M
  • LIDRW N/A
  • Earning Date
  • SRPT 05-06-2025
  • LIDRW N/A
  • Dividend Yield
  • SRPT N/A
  • LIDRW N/A
  • EPS Growth
  • SRPT N/A
  • LIDRW N/A
  • EPS
  • SRPT N/A
  • LIDRW N/A
  • Revenue
  • SRPT $2,233,371,000.00
  • LIDRW N/A
  • Revenue This Year
  • SRPT $64.51
  • LIDRW N/A
  • Revenue Next Year
  • SRPT $22.40
  • LIDRW N/A
  • P/E Ratio
  • SRPT N/A
  • LIDRW N/A
  • Revenue Growth
  • SRPT 59.15
  • LIDRW N/A
  • 52 Week Low
  • SRPT $35.46
  • LIDRW N/A
  • 52 Week High
  • SRPT $173.25
  • LIDRW N/A
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 22.68
  • LIDRW 52.15
  • Support Level
  • SRPT $35.46
  • LIDRW $0.05
  • Resistance Level
  • SRPT $64.80
  • LIDRW $0.06
  • Average True Range (ATR)
  • SRPT 3.78
  • LIDRW 0.02
  • MACD
  • SRPT -1.64
  • LIDRW 0.00
  • Stochastic Oscillator
  • SRPT 2.76
  • LIDRW 4.06

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About LIDRW AEye Inc. Warrant

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

Share on Social Networks: